Levodopa in the treatment of Parkinson's disease: A consensus meeting viewpointYves Agid, Eduardo Tolosa, Thomas N. Chase et al.|Movement Disorders|1999Cited by 88
Transdermal dopaminergic D<sub>2</sub> receptor agonist therapy in Parkinson's disease with N‐0923 TDS: A double‐blind, placebo‐controlled studyJ. Thomas Hutton, Jerry L. Morris, Leo Verhagen Metman et al.|Movement Disorders|2001Cited by 60